{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:51Z","timestamp":1787313411568,"version":"build-2736575974"},"reference-count":79,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2017.00040","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T02:04:19Z","timestamp":1490580259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters"],"prefix":"10.3389","volume":"8","author":[{"given":"Victor J.","family":"Geraedts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelie D.","family":"Andela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter K.","family":"Stalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sievers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"issue":"10","key":"B1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization","volume":"41","year":"1995","journal-title":"Soc Sci Med"},{"key":"B2","first-page":"11","article-title":"Quality of life studies: definitions and conceptual issues","volume-title":"Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Schipper","year":"1996","edition":"2nd ed."},{"issue":"2","key":"B3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"B4","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of co-morbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-12-0602","article-title":"Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register","volume":"168","author":"Schofl","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"B6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","article-title":"Quality of life in patients with a pituitary adenoma","volume":"6","author":"Johnson","year":"2003","journal-title":"Pituitary"},{"issue":"4","key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","article-title":"A consensus on the diagnosis and treatment of acromegaly complications","volume":"16","author":"Melmed","year":"2013","journal-title":"Pituitary"},{"issue":"6","key":"B9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1530\/eje.1.02292","article-title":"Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly","volume":"155","author":"Hua","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"B10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1530\/EJE-07-0356","article-title":"Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly","volume":"157","author":"T\u2019Sjoen","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"3\u20134","key":"B11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000095532","article-title":"Quality of life in acromegaly","volume":"83","author":"Webb","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","article-title":"Treatment of acromegaly improves quality of life, measured by AcroQol","volume":"67","author":"Paisley","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"B13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2265.2005.02307.x","article-title":"Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL)","volume":"63","author":"Trepp","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"B14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11102-008-0143-1","article-title":"Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study","volume":"12","author":"Sievers","year":"2009","journal-title":"Pituitary"},{"issue":"8 Suppl","key":"B15","first-page":"24","article-title":"The acromegalic arthropathy","volume":"28","author":"Colao","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"B16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2265.2009.03555.x","article-title":"Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients","volume":"71","author":"Sievers","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"B17","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"B18","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1210\/jc.2009-0474","article-title":"A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly","volume":"94","author":"Sucunza","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","year":"2009","journal-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)"},{"key":"B20","author":"Wells","year":"2014","journal-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12020-014-0166-5","article-title":"Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?","volume":"47","author":"Anagnostis","year":"2014","journal-title":"Endocrine"},{"issue":"3","key":"B22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1365-2265.2003.01710.x","article-title":"Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval","volume":"58","author":"Biermasz","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"B23","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"B24","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1210\/jc.2004-2297","article-title":"Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life","volume":"90","author":"Biermasz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"B25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/eje.1.01838","article-title":"The \u2019bio-assay\u2019 quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations","volume":"152","author":"Bonapart","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12902-016-0096-8","article-title":"Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study","volume":"16","author":"Bronstein","year":"2016","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"B27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11102-011-0298-z","article-title":"Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL","volume":"14","author":"Cannavo","year":"2011","journal-title":"Pituitary"},{"issue":"4","key":"B28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1210\/jc.2013-3318","article-title":"Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial","volume":"99","author":"Caron","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11102-015-0693-y","article-title":"Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study","volume":"19","author":"Caron","year":"2016","journal-title":"Pituitary"},{"issue":"6","key":"B30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1507\/endocrj.EJ12-0424","article-title":"Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center","volume":"60","author":"Celik","year":"2013","journal-title":"Endocr J"},{"issue":"6","key":"B31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3275\/8761","article-title":"Quality of life in female patients with acromegaly","volume":"36","author":"Celik","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"B32","doi-asserted-by":"publisher","first-page":"e006898","DOI":"10.1136\/bmjopen-2014-006898","article-title":"Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea","volume":"5","author":"Chin","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"B33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1590\/S0004-27302013000700009","article-title":"Physical activities in daily life and functional capacity compared to disease activity control in acromegalic patients: impact in self-reported quality of life","volume":"57","author":"Dantas","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6","key":"B34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1017\/cjn.2014.106","article-title":"Endoscopic transphenoidal surgery for acromegaly improves quality of life","volume":"41","author":"Fathalla","year":"2014","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1507\/endocrj.EJ16-0182","article-title":"Changes in quality of life in patients with acromegaly after surgical remission \u2013 a prospective study using SF-36 questionnaire","volume":"64","author":"Fujio","year":"2016","journal-title":"Endocr J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fendo.2014.00229","article-title":"Health outcomes in acromegaly: depression and anxiety are promising targets for improving reduced quality of life","volume":"5","author":"Geraedts","year":"2014","journal-title":"Front Endocrinol"},{"issue":"11","key":"B37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/BF03345774","article-title":"Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naive to radiation and medical therapy","volume":"32","author":"Ghigo","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11102-013-0463-7","article-title":"Impact of exercise on quality of life and body-self perception of patients with acromegaly","volume":"17","author":"Hatipoglu","year":"2014","journal-title":"Pituitary"},{"issue":"1","key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ghir.2014.12.003","article-title":"Acromegaly and aging: a comparative cross-sectional study","volume":"25","author":"Hatipoglu","year":"2015","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"B40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1365-2265.2011.04106.x","article-title":"Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly","volume":"75","author":"Karaca","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"B41","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1210\/jc.2006-0676","article-title":"Quality of life in treated patients with acromegaly","volume":"91","author":"Kauppinen-Makelin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"B42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11102-013-0544-7","article-title":"Impact of treatment satisfaction on quality of life of patients with acromegaly","volume":"17","author":"Kepicoglu","year":"2014","journal-title":"Pituitary"},{"issue":"9","key":"B43","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1210\/jc.2010-0394","article-title":"Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly","volume":"95","author":"Leon-Carrion","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/BF03346453","article-title":"Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly","volume":"32","author":"Lombardi","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"B45","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1210\/jc.2011-0654","article-title":"Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients","volume":"96","author":"Madsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"B46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11102-013-0533-x","article-title":"Biochemical and quality of life responses to octreotide-LAR in acromegaly","volume":"17","author":"Mangupli","year":"2014","journal-title":"Pituitary"},{"issue":"3","key":"B47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1530\/EJE-07-0697","article-title":"Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance","volume":"158","author":"Matta","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"B48","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00701-013-1809-7","article-title":"Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors \u2013 a longitudinal study of 106 patients","volume":"155","author":"Milian","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"B49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/EJE-07-0838","article-title":"Impact of musculoskeletal disease on quality of life in long-standing acromegaly","volume":"158","author":"Miller","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"B50","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1210\/jc.2008-0669","article-title":"Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant","volume":"93","author":"Neggers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"B51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/EJE-11-0853","article-title":"Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly","volume":"166","author":"Postma","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"B52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-0030-1267912","article-title":"Are there gender-specific differences concerning quality of life in treated acromegalic patients?","volume":"119","author":"Psaras","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"B53","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.3275\/7333","article-title":"Predictive factors for neurocognitive function and quality of life after surgical treatment for Cushing\u2019s disease and acromegaly","volume":"34","author":"Psaras","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"675310","DOI":"10.5402\/2012\/675310","article-title":"Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study","volume":"2012","author":"Raappana","year":"2012","journal-title":"ISRN Endocrinol"},{"issue":"6","key":"B55","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s10508-014-0309-z","article-title":"A missed diagnosis of acromegaly during a female-to-male gender transition","volume":"43","author":"Roerink","year":"2014","journal-title":"Arch Sex Behav"},{"issue":"6","key":"B56","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1210\/jc.2004-1565","article-title":"Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire","volume":"90","author":"Rowles","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"B57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1530\/EJE-10-0640","article-title":"Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery","volume":"163","author":"Rubeck","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"B58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF03346555","article-title":"Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study","volume":"33","author":"Sardella","year":"2010","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"B59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/s-0030-1267244","article-title":"Efficacy and acceptability of lanreotide Autogel(R) 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR","volume":"119","author":"Schopohl","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"B60","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","article-title":"Diagnostic delay is associated with psychosocial impairment in acromegaly","volume":"16","author":"Siegel","year":"2013","journal-title":"Pituitary"},{"issue":"4","key":"B61","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2265.2009.03620.x","article-title":"A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly","volume":"71","author":"Trainer","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"B62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","article-title":"Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly","volume":"69","author":"van der Klaauw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"B63","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12020-014-0521-6","article-title":"Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire","volume":"49","author":"Vandeva","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"B64","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/EC-14-0028","article-title":"In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life","volume":"3","author":"Varewijck","year":"2014","journal-title":"Endocr Connect"},{"issue":"3","key":"B65","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ghir.2010.02.003","article-title":"Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients","volume":"20","author":"Wassenaar","year":"2010","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"B66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/eje.1.02214","article-title":"Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study","volume":"155","author":"Webb","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"B67","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11102-015-0665-2","article-title":"The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL","volume":"18","author":"Yoshida","year":"2015","journal-title":"Pituitary"},{"issue":"3","key":"B68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-08-0896","article-title":"Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls","volume":"160","author":"Sievers","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/acr.20653","article-title":"Association of body mass index with symptom severity and quality of life in patients with fibromyalgia","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"B70","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/aje\/kwt053","article-title":"The impact of long-term body mass index patterns on health-related quality of life: the Doetinchem Cohort Study","volume":"178","author":"de Hollander","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"B71","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11102-011-0329-9","article-title":"The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism","volume":"15","author":"Turgut","year":"2012","journal-title":"Pituitary"},{"issue":"3","key":"B72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11102-010-0218-7","article-title":"Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population","volume":"13","author":"Dimopoulou","year":"2010","journal-title":"Pituitary"},{"issue":"2","key":"B73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4158\/EP11134.OR","article-title":"Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders","volume":"18","author":"Valassi","year":"2012","journal-title":"Endocr Pract"},{"issue":"2","key":"B74","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/jc.2009-1611","article-title":"Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement","volume":"95","author":"Miller","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"B75","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1210\/jc.2012-2477","article-title":"GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency","volume":"97","author":"Giavoli","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"B76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","article-title":"Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly","volume":"12","author":"van der Klaauw","year":"2009","journal-title":"Pituitary"},{"issue":"2","key":"B77","first-page":"63","article-title":"Complexity and non-linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation","volume":"36","author":"Ilias","year":"2002","journal-title":"Endocr Regul"},{"issue":"2","key":"B78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1054\/ghir.1999.0095","article-title":"Regular fluctuations in growth hormone (GH) release determine normal human growth","volume":"9","author":"Gill","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"B79","volume-title":"Biopsychosocial Aspects of Health and Disease","author":"Janowski","year":"2009"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:29:48Z","timestamp":1498382988000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2017.00040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":79,"URL":"https:\/\/doi.org\/10.3389\/fendo.2017.00040","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}